Biotech

All Articles

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.Operating system Therapies are going to provide on the NYSE American supply swap today by means of ...

ALX's fizzling CD47 feedback cost delivers sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells reaction price has compromised. After observing its CD4...

Ionis axes eye disease coming from targets of Roche-partnered prospect after data disappoint

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has disappointed desires, causing t...

Biogen's CEO mentioned no dangerous sell 2023. He's ready to become bold

.While Biogen's pharma peers are looking for late-stage resources with little bit of threat, chief e...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipeline after it ditched it...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually restored rights to an early Alzheimer's ailment program to Denali Therapies, go...

Takeda water faucets brand-new mind of US oncology business-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings and...

Vertex, beaten by AATD once again, goes down 2 assets on dispose of pile

.Tip's effort to address a rare hereditary disease has reached yet another obstacle. The biotech tos...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter earnings document wasn't short of huge information. The company ...

Galapagos stops CAR-T tissue therapy litigation over Parkinsonism situation

.Galapagos has actually stopped briefly application in a test of a BCMA-directed CAR-T cell treatmen...